Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,064.01
(
-0.63%
)
US TECH 100
25,895.20
(
0.09%
)
Dow Jones
49,149.38
(
-0.60%
)
Brent Oil
94.23
(
-0.83%
)
Bitcoin
77,537.00
(
1.58%
)
News Focus
News Focus
Post# of 447426
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

roadkilll

Send PM Follow Ignore
Followers 7
Posts 737
Boards Moderated 0
Alias Born 08/25/2012

roadkilll

Re: ziploc_1 post# 351499

Friday, 08/20/2021 12:30:01 PM

Friday, August 20, 2021 12:30:01 PM

Post# of 447426
Amarin is spending hundreds of millions to market Vascepa to patients and doctors for the CV risk reduction. If a doctor is putting a new patient on Vasecpa I'm guessing 99% are now related to the CV risk reduction.
Judge Du's decision is telling pharma a skinny label are the legal key needed to own the car that Amarin's hundreds of millions in research and marketing built.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News